| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
John M Climaco is Chief Executive Officer at CNSP and has filed Form 4s across 2 companies. John M Climaco's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Historically, John M Climaco's trades have earned a below-average insider score of 18/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -87.9%.
The biggest single holding is CNSP (~$981K) as Chief Executive Officer. Net of sales, the CNSP filings show accumulation of 184,416 shares.
John M Climaco has 24 Form 4 filings on record from January 2015 to November 2025, across 3 companies: Chief Executive Officer at CNS Pharmaceuticals (CNSP), 2021–2025; Director at Moleculin Biotech (MBRX), 2017–2025; Director at Perma Fix Environmental Services (PESI), 2015.
The 28 reported transactions were 19 option or other derivative awards, 5 stock awards, 3 open-market purchases and 1 option exercise.
Counted by filing, the open-market trades come to 3 purchases worth about $65K and no sales.
The largest open-market purchase was 166,666 shares of CNSP at an average $0.30 on February 1, 2024, about $50K. Twelve months later CNSP was down 99%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP Cns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 166,666 | $0.30 | $49,999.80 | +340.1% | -13.7% | -99.2% | |
| Aug 16, 2023 | CNSP Cns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,750 | $1.80 | $4,944.50 | +5.9% | -8.2% | -99.8% | |
| Apr 12, 2023 | CNSP Cns Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 15,000 | $0.69 | $10,408.50 | +50.0% | +240.7% | -64.8% |